View in EDS HTML Full Text PDF Full Text

Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.

Saved in:
Bibliographic Details
Title: Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
Authors: Hutchison RM; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA. matthew.hutchison@biogen.com., Evans KC; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA., Fox T; Biogen, Maidenhead, UK., Yang M; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA., Barakos J; Bioclinica, Princeton, NJ, USA., Bedell BJ; Biospective Inc., Montreal, QC, Canada., Cedarbaum JM; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA., Brys M; Eli Lilly and Company, Indianapolis, IN, USA., Siderowf A; University of Pennsylvania, Philadelphia, PA, USA., Lang AE; Morton and Gloria Shulman Movement Disorders Clinic, Toronto, ON, Canada.; Edmond J. Safra Program in Parkinson's Disease, Toronto, ON, Canada.
Source: BMC neurology [BMC Neurol] 2021 Nov 23; Vol. 21 (1), pp. 459. Date of Electronic Publication: 2021 Nov 23.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34814867
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hutchison+RM%22">Hutchison RM</searchLink>; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA. matthew.hutchison@biogen.com.<br /><searchLink fieldCode="AU" term="%22Evans+KC%22">Evans KC</searchLink>; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Fox+T%22">Fox T</searchLink>; Biogen, Maidenhead, UK.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; Biogen, 300 Binney Street, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Barakos+J%22">Barakos J</searchLink>; Bioclinica, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bedell+BJ%22">Bedell BJ</searchLink>; Biospective Inc., Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Cedarbaum+JM%22">Cedarbaum JM</searchLink>; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA.<br /><searchLink fieldCode="AU" term="%22Brys+M%22">Brys M</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Siderowf+A%22">Siderowf A</searchLink>; University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lang+AE%22">Lang AE</searchLink>; Morton and Gloria Shulman Movement Disorders Clinic, Toronto, ON, Canada.; Edmond J. Safra Program in Parkinson's Disease, Toronto, ON, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968555%22">BMC neurology</searchLink> [BMC Neurol] 2021 Nov 23; Vol. 21 (1), pp. 459. <i>Date of Electronic Publication: </i>2021 Nov 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2377 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712377%22">14712377 </searchLink><i>NLM ISO Abbreviation: </i>BMC Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34814867
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12883-021-02470-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 459
    Titles:
      – TitleFull: Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hutchison RM
      – PersonEntity:
          Name:
            NameFull: Evans KC
      – PersonEntity:
          Name:
            NameFull: Fox T
      – PersonEntity:
          Name:
            NameFull: Yang M
      – PersonEntity:
          Name:
            NameFull: Barakos J
      – PersonEntity:
          Name:
            NameFull: Bedell BJ
      – PersonEntity:
          Name:
            NameFull: Cedarbaum JM
      – PersonEntity:
          Name:
            NameFull: Brys M
      – PersonEntity:
          Name:
            NameFull: Siderowf A
      – PersonEntity:
          Name:
            NameFull: Lang AE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 11
              Text: 2021 Nov 23
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2377
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC neurology
              Type: main
ResultId 1